Skip to main content
Figure 3 | Cancer Cell International

Figure 3

From: Experimental study on the regulation of erlotinib-induced radiosensitization with an anti-c-MET monoclonal antibody

Figure 3

Inhibition of c-MET activity further enhances the radiosensitizing effect of erlotinib. Compared to the combined erlotinib(20NM) and radiation group, inhibition of the c-MET signaling pathway using a monoclonal antibody(10 nM) further decreased the survival fraction and enhanced the radiosensitizing effect (ANOVA analysis, P < 0.05) (A) Radiation group. (B) Combined erlotinib and radiation group. (C) Combined erlotinib and radiation with anti-c-MET monoclonal antibody treatment group.

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us